Phase 1 Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials
6 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–6 of 6 trials
Recruiting
Phase 1Phase 2
cfMSC Stem Cell Therapy Targeting COPD
Chronic Obstructive Pulmonary Disease (COPD)
Shenzhen Geno-Immune Medical Institute30 enrolled1 locationNCT07477600
Recruiting
Phase 1
A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Chronic Obstructive Pulmonary Disease (COPD)
Bambusa Therapeutics68 enrolled11 locationsNCT07288554
Recruiting
Phase 1
A Clinical Study of TQC3721 Inhalation Powder in Patients With Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease (COPD)
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.72 enrolled1 locationNCT06748079
Completed
Phase 1
Comparative assessment of the absorption of a generic formulation of tiotropium test product 1 and tiotropium test product 2 against the innovator Spiriva HandiHaler conducted under fasting conditions in healthy male and female volunteers
Bioavailability study conducted in healthy volunteers comparing three formulations of tiotropium with no health condition or problem studied.
Tiotropium is a long-acting, antimuscarinic agent, which is often referred to as an anticholinergic and is used to make breathing easier for people with Chronic Obstructive Pulmonary Disease (COPD).
Zenith Technology Corp Ltd24 enrolled1 locationACTRN12615000073505
Completed
Phase 1
Randomised trial comparing controlled oxygen therapy with high-flow oxygen therapy in the treatment of patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) in the pre-hospital setting
Chronic Obstructive Pulmonary Disease (COPD)
Associate Professor Richard Wood-Baker150 enrolled1 locationACTRN12609000236291
Completed
Phase 1
Trial of nurse and GP partnership for care of COPD
Chronic Obstructive Pulmonary Disease (COPD)
Prof Nicholas Zwar400 enrolled1 locationACTRN12606000304538